13(S)-HpODE augments epidermal growth factor signal transduction by attenuating EGF receptor dephosphorylation.
Glasgow
W C
WC
Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, Georgia 31207, USA.
Hui
R
R
Jayawickreme
S
S
Angerman-Stewart
J
J
Han
B B
BB
Eling
T E
TE
D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D004357:Drug Synergism; D004815:Epidermal Growth Factor / Q000008:administration & dosage* / Q000378:metabolism; D066246:ErbB Receptors / Q000187:drug effects* / Q000378:metabolism*; D007700:Kinetics; D008041:Linoleic Acids / Q000008:administration & dosage* / Q000378:metabolism; D008054:Lipid Peroxides / Q000008:administration & dosage* / Q000378:metabolism; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D010766:Phosphorylation; D015398:Signal Transduction / Q000187:drug effects
D008041:Linoleic Acids; D008054:Lipid Peroxides; C038649:13-hydroperoxy-9,11-octadecadienoic acid; D004815:Epidermal Growth Factor; D066246:ErbB Receptors; D020928:Mitogen-Activated Protein Kinases